Cyclic nucleotide phosphodiesterase activities in rat erythrocytes
- PMID: 6283333
- DOI: 10.1007/BF00223007
Cyclic nucleotide phosphodiesterase activities in rat erythrocytes
Abstract
Erythrocyte soluble phosphodiesterase activities show at least two interconvertible states: "aggregated' and "non-aggregated'. In the former state the existence of a high affinity component for cyclic AMP is favoured and the system is more active with cyclic AMP than with cyclic GMP as substrate. When the system is in the "non-aggregated state', no activity with cyclic GMP is detected. Conversion to the "non-aggregated state' is enhanced by dilution or by addition of magnesium ions. Upon isoelectric focusing of erythrocyte soluble extracts. Phosphodiesterase activities can be resolved in two peaks: one specific for cyclic AMP located at pH 4.66 and the other specific for cyclic GMP focused at pH 4.95. Evidence would indicate that aggregation affects the enzyme specific for cyclic AMP.
Similar articles
-
Resolution of soluble cyclic nucleotide phosphodiesterase isoenzymes, from liver and hepatocytes, identifies a novel IBMX-insensitive form.Biochem Pharmacol. 1989 Nov 15;38(22):4123-36. doi: 10.1016/0006-2952(89)90694-1. Biochem Pharmacol. 1989. PMID: 2480793
-
3':5'-cyclic-nucleotide phosphodiesterase in the bovine pituitary gland.Biochim Biophys Acta. 1983 Feb 22;755(3):481-7. doi: 10.1016/0304-4165(83)90253-2. Biochim Biophys Acta. 1983. PMID: 6297613
-
Cyclic AMP phosphodiesterase and cyclic GMP phosphodiesterase activities of rat mammary tissue.Biochem J. 1984 May 1;219(3):801-9. doi: 10.1042/bj2190801. Biochem J. 1984. PMID: 6331397 Free PMC article.
-
[Modern representations of multiple forms of cyclic nucleotide phosphodiesterases in mammalian tissues].Biokhimiia. 1995 Mar;60(3):364-86. Biokhimiia. 1995. PMID: 7734612 Review. Russian.
-
Multiplicity within cyclic nucleotide phosphodiesterases.Biochem Soc Trans. 1996 Nov;24(4):1005-9. doi: 10.1042/bst0241005. Biochem Soc Trans. 1996. PMID: 8968501 Review. No abstract available.